Results 251 to 260 of about 66,247 (299)

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy. [PDF]

Am J Hematol
Origa R, Gianesin B, Zappu A, Denotti AR, Di Giorgio MA, Sciortino R, Motta I, Panzieri DL, Rosso R, Bulla A, Culcasi M, Pasanisi AM, De Franceschi L, Di Maggio R, Pinto VM, Sanna PMG, Ricchi P, Ruffo GB, Schieppati F, Roberti D, Ferrero GB, De Michele E, Arcioni F, Fotzi I, Marktel S, Poloni A, Soverini G, Testa ER, Cabiddu G, Fortugno C, Gigante A, Polese F, Rapezzi D, Sau A, Forni GL, Cappellini MD, Longo F.   +36 more
europepmc   +1 more source

Inter-Organelle Crosstalk in Oxidative Distress: A Unified TRPM2-NOX2 Mediated Vicious Cycle Involving Ca²⁺, Zn²⁺, and ROS Amplification. [PDF]

Antioxidants (Basel)
Shitaw EE, AlAhmad M, Sivaprasadarao A.
europepmc   +1 more source

Correction for Bizup et al., Cochlear zinc signaling dysregulation is associated with noise-induced hearing loss, and zinc chelation enhances cochlear recovery. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Chelation and Catalysis

, 1953
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

To chelate or not to chelate in MDS: That is the question!

Blood Reviews, 2018
Myelodysplastic syndromes (MDS) are a heterogeneous group of hemopathies that exhibit physical manifestations with clinical consequences of bone marrow failure and inherent risk of progression to acute myeloid leukemia. Iron overload (IO) is common in MDS due to chronic transfusion support and disease-related alterations in iron metabolism. IO has been
Amer M. Zeidan, Elizabeth A. Griffiths
openaire   +3 more sources